Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 12 2018
accepted: 26 11 2019
pubmed: 29 1 2020
medline: 21 7 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

The microbiota has been shown to promote intestinal tumourigenesis, but a possible anti-tumourigenic effect has also been postulated. Here, we demonstrate that changes in the microbiota and mucus composition are concomitant with tumourigenesis. We identified two anti-tumourigenic strains of the microbiota-Faecalibaculum rodentium and its human homologue, Holdemanella biformis-that are strongly under-represented during tumourigenesis. Reconstitution of Apc

Identifiants

pubmed: 31988379
doi: 10.1038/s41564-019-0649-5
pii: 10.1038/s41564-019-0649-5
pmc: PMC7048616
mid: EMS85060
doi:

Substances chimiques

DNA, Bacterial 0
Fatty Acids, Volatile 0
RNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

511-524

Subventions

Organisme : European Research Council
ID : 615735
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Sears, C. L. & Garrett, W. S. Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317–328 (2014).
doi: 10.1016/j.chom.2014.02.007 pubmed: 24629338 pmcid: 4003880
Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
doi: 10.1101/gr.126573.111 pubmed: 22009990 pmcid: 3266036
Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin. Transl. Gastroenterol. 7, e200 (2016).
doi: 10.1038/ctg.2016.53 pubmed: 27811909 pmcid: 5543402
Yu, T. et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548–563 (2017).
doi: 10.1016/j.cell.2017.07.008 pubmed: 28753429 pmcid: 5767127
Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).
doi: 10.1016/S0092-8674(00)81333-1 pubmed: 8861899
Li, Y. et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APC
doi: 10.1093/carcin/bgs137 pubmed: 22461519
Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
doi: 10.1016/j.chom.2013.07.007 pubmed: 23954159 pmcid: 3772512
Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016–1022 (2009).
doi: 10.1038/nm.2015 pubmed: 19701202 pmcid: 3034219
Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012).
doi: 10.1126/science.1224820 pubmed: 22903521 pmcid: 3645302
Zhan, Y. et al. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res. 73, 7199–7210 (2013).
doi: 10.1158/0008-5472.CAN-13-0827 pubmed: 24165160
Wong, S. H. et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology 153, 1621–1633 (2017).
doi: 10.1053/j.gastro.2017.08.022 pubmed: 28823860
Donohoe, D. R. et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 4, 1387–1397 (2014).
doi: 10.1158/2159-8290.CD-14-0501 pubmed: 25266735 pmcid: 4258155
Chang, D. H. et al. Faecalibaculum rodentium gen. nov., sp. nov., isolated from the faeces of a laboratory mouse. Antonie Van Leeuwenhoek 108, 1309–1318 (2015).
doi: 10.1007/s10482-015-0583-3 pubmed: 26349481
Johansson, M. E. et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl Acad. Sci. USA 105, 15064–15069 (2008).
doi: 10.1073/pnas.0803124105 pubmed: 18806221 pmcid: 2567493
Xiao, X. et al. Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer. J. Transl. Med. 11, 151 (2013).
doi: 10.1186/1479-5876-11-151 pubmed: 23787019 pmcid: 3702436
Betge, J. et al. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. Virchows Arch. 469, 255–265 (2016).
doi: 10.1007/s00428-016-1970-5 pubmed: 27298226 pmcid: 5007278
Guglietta, S. et al. Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis. Nat. Commun. 7, 11037 (2016).
doi: 10.1038/ncomms11037 pubmed: 26996437 pmcid: 4802169
Sakamoto, M., Tanaka, Y., Benno, Y. & Ohkuma, M. Butyricimonas faecihominis sp. nov. and Butyricimonas paravirosa sp. nov., isolated from human faeces, and emended description of the genus Butyricimonas. Int. J. Syst. Evol. Microbiol. 64, 2992–2997 (2014).
doi: 10.1099/ijs.0.065318-0 pubmed: 24903545
Singh, N. et al. Activation of gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128–139 (2014).
doi: 10.1016/j.immuni.2013.12.007 pubmed: 24412617 pmcid: 4305274
Boffa, L. C., Vidali, G., Mann, R. S. & Allfrey, V. G. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 253, 3364–3366 (1978).
pubmed: 649576
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
doi: 10.1126/science.1160809
Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48, 612–626 (2012).
doi: 10.1016/j.molcel.2012.08.033 pubmed: 23063526 pmcid: 3513569
Peuker, K. et al. Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat. Med. 22, 506–515 (2016).
doi: 10.1038/nm.4072 pubmed: 27043494 pmcid: 5570457
Imai, Y. et al. Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma. JCI Insight 1, e85061 (2016).
doi: 10.1172/jci.insight.85061 pubmed: 27699258 pmcid: 5033869
Han, K. J., Lee, N. K., Park, H. & Paik, H. D. Anticancer and anti-inflammatory activity of probiotic Lactococcus lactis NK34. J. Microbiol. Biotechnol. 25, 1697–1701 (2015).
doi: 10.4014/jmb.1503.03033 pubmed: 26165315
Zeller, G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).
doi: 10.15252/msb.20145645 pubmed: 25432777 pmcid: 4299606
Tsilingiri, K., Sonzogni, A., Caprioli, F. & Rescigno, M. A novel method for the culture and polarized stimulation of human intestinal mucosa explants. J. Vis. Exp. 75, e4368 (2013).
Kesari, M. V. et al. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature. Indian J. Gastroenterol. 34, 63–67 (2015).
doi: 10.1007/s12664-015-0534-y pubmed: 25731647
Yan, X., Liu, L., Li, H., Qin, H. & Sun, Z. Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients. Onco Targets Ther. 10, 5031–5046 (2017).
doi: 10.2147/OTT.S145949 pubmed: 29081665 pmcid: 5652912
Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).
doi: 10.1126/science.aal5240 pubmed: 29170280 pmcid: 5823247
Mendes, R. T. et al. Endothelial cell response to Fusobacterium nucleatum. Infect. Immun. 84, 2141–2148 (2016).
doi: 10.1128/IAI.01305-15 pubmed: 27185790 pmcid: 4936358
Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344–355 (2015).
doi: 10.1016/j.immuni.2015.01.010 pubmed: 25680274 pmcid: 4361732
Chen, Y. et al. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade. Oncotarget 8, 31802–31814 (2017).
pubmed: 28423670 pmcid: 5458249
Chung, L. et al. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host Microbe 23, 203–214 (2018).
Dejea, C. M. et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359, 592–597 (2018).
doi: 10.1126/science.aah3648 pubmed: 29420293 pmcid: 5881113
Yan, F. et al. Interleukin-13-induced MUC5AC expression is regulated by a PI3K–NFAT3 pathway in mouse tracheal epithelial cells. Biochem. Biophys. Res. Commun. 446, 49–53 (2014).
doi: 10.1016/j.bbrc.2014.02.051 pubmed: 24583134
San-Millan, I. & Brooks, G. A. Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect. Carcinogenesis 38, 119–133 (2017).
pubmed: 27993896
Faubert, B. et al. Lactate metabolism in human lung tumors. Cell 171, 358–371 (2017).
doi: 10.1016/j.cell.2017.09.019 pubmed: 28985563 pmcid: 5684706
Duncan, S. H., Louis, P. & Flint, H. J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70, 5810–5817 (2004).
doi: 10.1128/AEM.70.10.5810-5817.2004 pubmed: 15466518 pmcid: 522113
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
doi: 10.1126/science.aad3369 pubmed: 27126040 pmcid: 5240844
De Maesschalck, C. et al. Faecalicoccus acidiformans gen. nov., sp. nov., isolated from the chicken caecum, and reclassification of Streptococcus pleomorphus (Barnes et al. 1977), Eubacterium biforme (Eggerth 1935) and Eubacterium cylindroides (Cato et al. 1974) as Faecalicoccus pleomorphus comb. nov., Holdemanella biformis gen. nov., comb. nov. and Faecalitalea cylindroides gen. nov., comb. nov., respectively, within the family Erysipelotrichaceae. Int. J. Syst. Evol. Microbiol. 64, 3877–3884 (2014).
doi: 10.1099/ijs.0.064626-0 pubmed: 25180093
Atarashi, K. et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 500, 232–236 (2013).
doi: 10.1038/nature12331 pubmed: 23842501
Moser, A. R., Pitot, H. C. & Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322–324 (1990).
doi: 10.1126/science.2296722 pubmed: 2296722
Furet, J. P. et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 68, 351–362 (2009).
doi: 10.1111/j.1574-6941.2009.00671.x pubmed: 19302550
Manzari, C. et al. Draft genome sequence of Sphingobium sp. strain ba1, resistant to kanamycin and nickel ions. FEMS Microbiol. Lett. 361, 8–9 (2014).
doi: 10.1111/1574-6968.12618 pubmed: 25288103
Fosso, B. et al. BioMaS: a modular pipeline for bioinformatic analysis of metagenomic amplicons. BMC Bioinform. 16, 203 (2015).
doi: 10.1186/s12859-015-0595-z
Zhang, J, Kobert, K, Flouri, T. & Stamatakis, A. PEAR: a fast and accurate Illumina paired-end read merger. Bioinformatics 30, 614–620 (2014).
Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).
doi: 10.1093/bioinformatics/btq461 pubmed: 20709691
Cole, J. R. et al. The ribosomal database project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37, D141–D145 (2009).
doi: 10.1093/nar/gkn879 pubmed: 19004872
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923 pubmed: 22388286 pmcid: 3322381
Alonso-Alemany, D. et al. Further steps in TANGO: improved taxonomic assignment in metagenomics. Bioinformatics 30, 17–23 (2014).
doi: 10.1093/bioinformatics/btt256 pubmed: 23645816
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
doi: 10.1186/gb-2011-12-6-r60 pubmed: 21702898 pmcid: 3218848
Salzman, N. H. et al. Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect. Immun. 71, 1109–1115 (2003).
doi: 10.1128/IAI.71.3.1109-1115.2003 pubmed: 12595421 pmcid: 148886
Oksanen, J. et al. Vegan: community ecology package. R package vegan version 2.2-1 (2015); https://cran.r-project.org/web/packages/vegan/index.html
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2009).
Cooper, H. S., Murthy, S. N., Shah, R. S. & Sedergran, D. J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238–249 (1993).
pubmed: 8350599
Boivin, G. P. et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124, 762–777 (2003).
doi: 10.1053/gast.2003.50094 pubmed: 12612914
Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015).
doi: 10.1038/nmeth.3589 pubmed: 26418763
Pasolli, E. et al. Accessible, curated metagenomic data through ExperimentHub. Nat. Methods 14, 1023–1024 (2017).
doi: 10.1038/nmeth.4468 pubmed: 29088129 pmcid: 5862039
Segata, N., Bornigen, D., Morgan, X. C. & Huttenhower, C. PhyloPhlAn is a new method for improved phylogenetic and taxonomic placement of microbes. Nat. Commun. 4, 2304 (2013).
doi: 10.1038/ncomms3304 pubmed: 23942190
Gargari, G. et al. Consumption of a Bifidobacterium bifidum strain for 4 weeks modulates dominant intestinal bacterial taxa and fecal butyrate in healthy adults. Appl. Environ. Microbiol. 82, 5850–5859 (2016).
doi: 10.1128/AEM.01753-16 pubmed: 27451450 pmcid: 5038021
Tuominen, V. J., Ruotoistenmaki, S., Viitanen, A., Jumppanen, M. & Isola, J. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 12, R56 (2010).
doi: 10.1186/bcr2615 pubmed: 20663194 pmcid: 2949645

Auteurs

Elena Zagato (E)

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.

Chiara Pozzi (C)

Humanitas Clinical and Research Center, IRCCS, Milan, Italy.

Alice Bertocchi (A)

Humanitas Clinical and Research Center, IRCCS, Milan, Italy.

Tiziana Schioppa (T)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Fabiana Saccheri (F)

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Silvia Guglietta (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.

Bruno Fosso (B)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Consiglio Nazionale delle Ricerche, Bari, Italy.

Laura Melocchi (L)

Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Pathology Department, Fondazione Poliambulanza Hospital, Brescia, Italy.

Giulia Nizzoli (G)

Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Jacopo Troisi (J)

Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, SA, Italy.
Theoreo Srl, Montecorvino Pugliano, Italy.
European Biomedical Research Institute of Salerno, Salerno, Italy.

Marinella Marzano (M)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Consiglio Nazionale delle Ricerche, Bari, Italy.

Bianca Oresta (B)

Humanitas Clinical and Research Center, IRCCS, Milan, Italy.

Ilaria Spadoni (I)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Koji Atarashi (K)

RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Japan.
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Sara Carloni (S)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Stefania Arioli (S)

Division of Food Microbiology and Bioprocesses and Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Milan, Italy.

Giulia Fornasa (G)

Humanitas Clinical and Research Center, IRCCS, Milan, Italy.

Francesco Asnicar (F)

CIBIO Department, University of Trento, Trento, Italy.

Nicola Segata (N)

CIBIO Department, University of Trento, Trento, Italy.

Simone Guglielmetti (S)

Division of Food Microbiology and Bioprocesses and Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Milan, Italy.

Kenya Honda (K)

RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Japan.
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Graziano Pesole (G)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Consiglio Nazionale delle Ricerche, Bari, Italy.
Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, Bari, Italy.

William Vermi (W)

Section of Pathology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Department of Pathology and Immunology, Washington University, Saint Louis, MO, USA.

Giuseppe Penna (G)

Humanitas Clinical and Research Center, IRCCS, Milan, Italy.

Maria Rescigno (M)

Humanitas Clinical and Research Center, IRCCS, Milan, Italy. maria.rescigno@hunimed.eu.
Department of Biomedical Sciences, Humanitas University, Milan, Italy. maria.rescigno@hunimed.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH